Skip to content

Mindfulness as an add-on Intervention in Treatment for Problem Gambling in Clinical Settings in Sweden

Mindfulness as an add-on Intervention in Treatment for Problem Gambling - a Randomized Control Trial and a Qualitative Analysis in Clinical Settings in Sweden

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06561139
Enrollment
60
Registered
2024-08-19
Start date
2024-08-15
Completion date
2026-12-31
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Problem Gambling

Keywords

Problem gambling, Mindfulness

Brief summary

This study will test the effects of an add-on mindfulness intervention for patients with gambling problems, added to treatment as usual, compared to a waitlist control condition. The study will primarily aim to decrease gambling behaviour compared to the control condition which receives the intervention later, after two months, and secondarily to decrease symptoms of depressive and anxiety symptoms. In addition, patients who have undergone the mindfulness intervention will be offered participation in a qualitative interview study aiming to deepen the understanding of feasibility and challenges of a mindfulness add-on intervention against gambling problems.

Interventions

BEHAVIORALMindfulness

Weekly group sessions of mindfulness, for eight weeks

Sponsors

Lund University
CollaboratorOTHER
Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized control trial, and subsequently a qualitative study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled in any kind of treatment for problem gambling at a regional health care unit for problem gambling or at any municipal social service unit for problem gambling, and who provides informed consent

Exclusion criteria

* Inability to provide informed consent due to language difficulties or due to severe mental health problems, or because of mental health problems requiring urgent psychiatric management (such as suicidal, homicidal, delirious or psychotic behavior)

Design outcomes

Primary

MeasureTime frameDescription
Change in past 30-day gambling (NODS 30 days)Post-treatment (treatment completion) and 3 and 12 months after end of treatmentChange in the number of criteria met according to a diagnostic tool for gambling disorder, but measuring the past 30 days at baseline and at post-treatment, and 3 and 12 months post-treatment

Secondary

MeasureTime frameDescription
Change in past-2-week depressive symptomsPost-treatment (treatment completion) and 3 and 12 months after end of treatmentChange in scores on Patient Health Questionnaire-9, a well-recognised instrument measuring past-2-week depressive symptoms
Change in past-2-week anxiety symptomsPost-treatment (treatment completion) and 3 and 12 months after end of treatmentChange in scores on Generalised Anxiety Disorder-7, a well-recognised instrument measuring past-2-week anxiety symptoms

Countries

Sweden

Contacts

Primary ContactAnders Håkansson, PhD
anders_c.hakansson@med.lu.se+46 46 175596
Backup ContactPatrick Bacquin, nurse
patrick.bacquin@skane.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026